Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Stifel reiterated a Buy rating on Edwards Lifesciences and kept a $110 price target, implying roughly 27% upside from the current share price. The medical device maker posted stronger-than-expected fourth-quarter 2025 revenue driven largely by transcatheter aortic valve replacement (TAVR) sales, while adjusted EPS lagged estimates due to higher sel…
Stifel has reconfirmed a Buy rating and set a $160 price target on Glaukos Corporation (GKOS), citing an attractive risk-reward for the company’s iDose franchise even as potential Local Coverage Determination - LCD - restrictions loom. The firm’s assessment rests on survey work, early commercial checks, and recent company disclosures including prel…
National Bank Financial moved Vizsla Silver Corp (NYSE:VZLA) from Outperform to Sector Perform after security incidents at the company’s Panuco project in Mexico. The downgrade follows reports that 10 people were removed from the site on January 28 and that several of those taken were later found deceased, announced on February 9. The research firm…
Stifel has reduced its 12-month price objective on S&P Global to $489.00 from $599.00 while keeping a Buy rating. The move follows the company’s latest quarterly results and 2026 guidance, which Stifel says came in below expectations. The research firm points to an investor narrative around AI-driven disruption - a narrative it finds hard to counte…
Baird raised its rating on Medpace (NASDAQ: MEDP) from Neutral to Outperform and set a $564.00 price target, implying roughly 32% upside from the stock's quoted $428.16 level. The upgrade, executed intraday and described by Baird as a rare move for the firm, leans on Medpace’s artificial intelligence strengths even as the company reported a strong …
Evercore ISI trimmed its price target on Urban Edge Properties to $21.00 from $22.00 while keeping an "In Line" rating. The research shop marginally reduced its FFO estimate to $1.50 from $1.51, citing slightly lower cash net operating income projections that were partially offset by reduced general and administrative expenses. The REIT's leasing p…
A Jefferies note says Chinese developers now occupy three of the top five global rankings for agentic AI performance and six of the top ten overall. The report highlights rising enterprise adoption of agents, a shrinking performance gap with U.S. models, and a pricing advantage for Chinese systems, while cautioning that widespread corporate deploym…
Lyft is oversold after a revenue miss but is generating strong adjusted EBITDA and free cash flow. At a market cap of roughly $5.7B and free cash flow north of $1.0B, the setup favors a tactical long while bookings and margin expansion reassert themselves. Technicals are stretched, which creates a defined risk-reward for a swing trade.
Incyte shares pulled back after guidance commentary and a mixed readout cycle. The drop looks driven by sentiment and short-volume pressure rather than a lasting hit to profitability or balance sheet strength. With a market cap near $19.5B, a healthy free cash flow stream and negligible debt, Incyte is a candidate for a tactical long on a mean-reve…
Stifel increased its price target on Ecolab Inc. to $337 from $300 and retained a Buy rating. The move follows fourth-quarter 2025 adjusted EBIT margin improvement and company guidance for additional margin gains in 2026. Ecolab also reported record Q4 2025 EPS of $2.08 on revenue of $4.19 billion and maintained its revenue outlook.
Cantor Fitzgerald trimmed its 12-month price target for BlackLine to $50 from $58 while keeping a Neutral rating, citing that the company’s 2025 results were encouraging but that sustained improvement would be required to restore low double-digit growth. The stock is trading near its 52-week low and carries a high P/E, and analysts remain divided o…
Cantor Fitzgerald reduced its price target for Jumia Technologies (JMIA) from $18.00 to $16.00 while retaining an Overweight rating. The revised target still implies material upside from Jumia's last-traded price of $9.86. Cantor pointed to accelerating gross merchandise value (GMV) trends and multi-quarter guidance that support sustained revenue e…
Jefferies increased its price objective on James Hardie Industries to AUD33.00 from AUD30.00 and kept a Buy rating after the building materials maker posted fiscal Q3 results that beat several Street estimates. The quarter was driven by siding performance, stronger margins and raised guidance for fiscal 2026, prompting at least one other broker, Tr…
Cantor Fitzgerald trimmed its price objective for Klaviyo Inc. (NYSE:KVYO) to $35 from its prior target while retaining an Overweight rating. The new target implies roughly 65% upside from the most recent share price of $21.20. The move follows a quarter of stronger-than-expected top-line growth, improved free cash flow margins and rising revenue f…
Stifel on Wednesday raised its price target for Aramark Holdings (NYSE: ARMK) to $47 from $44 and kept a Buy rating after the company delivered a quarter Stifel described as "solid." The firm made only minor changes to its financial model and left its fiscal 2026 and 2027 EPS estimates essentially unchanged, while incorporating calendar year 2027 e…
Stifel reduced its price target on Norwegian Cruise Line Holdings to $31 from $32 while retaining a Buy rating, pointing to weakening short-term pricing power as Caribbean capacity rises. The stock trades near $22.84, leaving roughly 13% upside to analyst consensus targets, and recent broker activity has delivered a range of downgrades and target c…
Palantir is selling an OS for mission-critical autonomy and operational AI. Q4 2025 results and large commercial deal flow show accelerating adoption; trading near $135 after a pullback creates a tradeable long with defined risk. The thesis: the market re-rates as Palantir converts performance obligations into recurring enterprise deployments, but …
Norway's equity benchmark closed higher on Wednesday, with the Oslo OBX up 0.52% to a fresh record. Gains were concentrated in Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities, while a handful of large-cap stocks finished lower. Oil and other commodity prices were higher, and currency moves were modest.
Israel's equity market closed lower Wednesday with the TA-35 falling 0.79%. Gains in a handful of large-cap names were outweighed by losses in Communication, Technology and Biomed sectors. Market breadth favored decliners, while oil, Brent and gold rose and the shekel weakened slightly versus the dollar and euro.
Red Cat (RCAT) has shifted from development to production: Q4 revenue of $24-26.5M and a $35M production contract give the stock a fresh fundamental story. With an upcoming Innovation Day likely to spotlight new products and production scale, we outline a swing trade to capture an event-driven re-rate while controlling downside with a defined stop.
Greece's Athens General Composite finished Wednesday's session up 0.02%, with gains concentrated in the Construction, Travel and Technology sectors. Austriacard Holdings, Coca Cola HBC and Alumil were the session's top performers, while Qualco Group, Alpha Bank and Performance Technologies led declines. Broader market breadth was negative, and comm…
Cantor Fitzgerald trimmed its 12-month price objective on Spotify to $525 from $615 and kept a Neutral rating, even after the company posted fourth-quarter results that beat some expectations on margins and subscriber growth. The firm said operating income exceeded prior Street estimates and highlighted improving margins driven by favorable content…
A Turin pre-trial judge has dismissed John Elkann’s proposal to resolve a tax fraud allegation by performing community service. The decision leaves open the prospect of a criminal trial, while a separate financial payment intended to settle administrative aspects of the inheritance dispute has already been completed.
JPMorgan downgraded AtriCure Inc. from Overweight to Neutral and trimmed its target to $36 from $48 following Edwards Lifesciences’ announcement of a surgical left atrial appendage closure (LAAC) product that will compete with AtriCure’s AtriClip. The research note cites Edwards’ deep footprint in cardiac surgery and the potential risk to AtriCure’…
Cantor Fitzgerald reduced its price target on Zillow Group to $56 from $68 and kept a Neutral rating after the company reported fourth-quarter results showing revenue modestly above expectations but EBITDA slightly below. Zillow reported $2.58 billion in revenue, with For Sale and Rentals segments showing disparate growth patterns. Management guide…
